142 related articles for article (PubMed ID: 7184392)
1. [NK activities in cancer patients--their modification by an immunopotentiator].
Sasanami T; Fujishima A; Moriya Y; Imai K; Yachi A
Gan To Kagaku Ryoho; 1982 Dec; 9(12):2186-92. PubMed ID: 7184392
[TBL] [Abstract][Full Text] [Related]
2. [Observation on natural killer cell activity in gastric cancer patients and effect of nonspecific immunopotentiator administration on its postoperative reduction].
Oshita H; Saji S; Sugiyama Y; Tanemura H; Sakata K; Tanaka S; Ito T
Nihon Geka Gakkai Zasshi; 1985 Oct; 86(10):1417-25. PubMed ID: 4079897
[TBL] [Abstract][Full Text] [Related]
3. In vitro potentiation of human natural killer cell activity by a streptococcal preparation, OK-432: interferon and interleukin-2 participation in the stimulation with OK-432.
Wakasugi H; Kasahara T; Minato N; Hamuro J; Miyata M; Morioka Y
J Natl Cancer Inst; 1982 Oct; 69(4):807-12. PubMed ID: 6181282
[TBL] [Abstract][Full Text] [Related]
4. OK-432 stimulates primary production and activity of murine natural killer cells.
Pollack SB
Nat Immun Cell Growth Regul; 1987; 6(5):224-36. PubMed ID: 3444437
[TBL] [Abstract][Full Text] [Related]
5. [Oral administration of OK-432 (picibanil). (8th report) clinical application: its immunomodulatory effects on the patients with gastrointestinal cancers].
Nio Y; Ohgaki K; Tsuchitani T; Imai S; Shiraishi T; Tsubono M; Morimoto H; Tseng CC; Tobe T
Nihon Gan Chiryo Gakkai Shi; 1989 Aug; 24(8):1607-15. PubMed ID: 2809385
[TBL] [Abstract][Full Text] [Related]
6. [Antitumor effect of OK-432 (1)--antitumor effect of OK-432 induced interferon-gamma (IFN gamma)].
Saito M; Yamaguchi T; Aonuma E; Noda T; Edina T; Ishida N
Gan To Kagaku Ryoho; 1982 Nov; 9(11):2031-7. PubMed ID: 6820888
[TBL] [Abstract][Full Text] [Related]
7. Augmentation by OK-432 of generation of culture-induced killer cells.
Ujiie T
Jpn J Exp Med; 1987 Jun; 57(3):153-61. PubMed ID: 3682231
[TBL] [Abstract][Full Text] [Related]
8. [Correlation between enhancement of natural killer (NK) activity by an immunopotentiator (OK-432) and resistance to human hepatoma cell implantation in nude mice].
Saito H; Morizane T; Kumagai N; Inagaki Y; Nakamura T; Satoh I; Iino A; Matsumura S; Kawamura N; Tsuchiya M
Nihon Shokakibyo Gakkai Zasshi; 1985 Dec; 82(12):2923-9. PubMed ID: 3831444
[No Abstract] [Full Text] [Related]
9. Augmentation of natural killer (NK) cell activity by a streptococcal preparation, OK-432, in patients with malignant tumors.
Wakasugi H; Oshimi K; Miyata M; Morioka Y
J Clin Immunol; 1981 Jul; 1(3):154-62. PubMed ID: 6174541
[TBL] [Abstract][Full Text] [Related]
10. Augmentation of autologous tumor killing activity of tumor-associated large granular lymphocytes by the streptococcal preparation OK432.
Uchida A
Methods Find Exp Clin Pharmacol; 1986 Feb; 8(2):81-4. PubMed ID: 2423823
[TBL] [Abstract][Full Text] [Related]
11. Effect of biological response modifier-streptococcal preparation OK-432 on NK/K cell system of gnotobiotic miniature swine.
Kim YB
Prog Clin Biol Res; 1985; 181():337-41. PubMed ID: 4063011
[No Abstract] [Full Text] [Related]
12. [In vitro effects of X-irradiation on NK activity and its augmentation by OK-432 treatment].
Nesumi N; Konishi J; Misaki T; Ono K; Abe M; Torizuka K
Nihon Igaku Hoshasen Gakkai Zasshi; 1985 May; 45(5):752-63. PubMed ID: 4047930
[No Abstract] [Full Text] [Related]
13. [Antitumor activity of neutrophils induced by a nonspecific immunopotentiator OK-432. III. Experimental study using human peripheral neutrophils].
Umemoto T; Saji S; Enami H; Kunii Y; Goshima H; Tachibana S; Takao H; Sakata K
Nihon Gan Chiryo Gakkai Shi; 1988 Jul; 23(7):1518-24. PubMed ID: 3183460
[No Abstract] [Full Text] [Related]
14. Enhanced generation of OK-432-induced killer cells by interleukin 2.
Ujiie T
Jpn J Exp Med; 1987 Jun; 57(3):183-8. PubMed ID: 3500332
[TBL] [Abstract][Full Text] [Related]
15. Modulation of NK activity in regional lymph nodes by preoperative immunotherapy with OK-432 in patients with cancer of the oral cavity.
Vinzenz K; Matejka M; Watzek G; Porteder H; Neuhold N; Micksche M
Cancer Detect Prev Suppl; 1987; 1():463-75. PubMed ID: 3480060
[TBL] [Abstract][Full Text] [Related]
16. Augmentation of mouse natural killer cell activity by a streptococcal preparation, OK-432.
Oshimi K; Kano S; Takaku F; Okumura K
J Natl Cancer Inst; 1980 Dec; 65(6):1265-9. PubMed ID: 7001124
[TBL] [Abstract][Full Text] [Related]
17. Effect of streptococcal lyzate OK-432 on peripheral blood mononuclear cells in gastric cancer patients.
Nakayama F; Iwagaki H; Gouchi A; Hizuta A; Isozaki H; Takakura N; Tanaka N
J Med; 1998; 29(3-4):199-215. PubMed ID: 9865458
[TBL] [Abstract][Full Text] [Related]
18. Effect of OK-432 on cytotoxic activity in cancer patients without tumor burden.
Fujieda S; Saito H; Isobe Y; Nakagawara G; Nishi O; Nagahara K; Watanabe Y; Hoshino T
Anticancer Res; 1992; 12(6B):1941-5. PubMed ID: 1341892
[TBL] [Abstract][Full Text] [Related]
19. [Effective mechanisms of BRM, with special reference to induction of autologous tumor cell-killing (ATK) activity by OK-432].
Hoshino T; Uchida A
Gan To Kagaku Ryoho; 1986 Apr; 13(4 Pt 2):1277-84. PubMed ID: 3488024
[TBL] [Abstract][Full Text] [Related]
20. Decreased response to interleukin-2 of cancer patients in terms of augmentation of natural killer cell activity.
Abe Y; Ajitsu S; Hamuro J; Ishikawa M; Sendo F
Jpn J Cancer Res; 1985 Oct; 76(10):1003-7. PubMed ID: 3935618
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
